Herasight is a genetic screening company that charges $50,000 to allow hopeful parents to analyze embryos for genetic information like lifespan, height and IQ in life.
Source link
The Abbott manufacturing facility in Sturgis, Michigan, on May 13, 2022.Jeff Kowalsky | AFP | Getty ImagesShares of Abbott Laboratories popped Wednesday after the...
Francis deSouza, chief executive officer of Illumina Inc., during a panel session on day three of the World Economic Forum (WEF) in Davos, Switzerland,...
There's a big buying opportunity in DigitalBridge , an under-the-radar digital infrastructure company, according to Deutsche Bank. Analyst Matthew Niknam initiated the stock with...
